Biodexa to Raise Approximately $2.3 Million via Warrant Exercise and New Warrant Issuance

Filing content

The company entered into an agreement to reduce the exercise price of existing warrants to $1.05 and issue new Series P warrants, anticipating gross proceeds of approximately $2.3 million.